Kimberly-Clark to Acquire Kenvue
Kimberly-Clark has announced a cash and stock acquisition of Kenvue, the maker of Tylenol, valued at approximately $48.7 billion.
Merger Details
Upon completion, Kimberly-Clark shareholders will own about 54% of the combined company, while Kenvue shareholders will hold 46%.
Combined Brands
The merger brings together a range of popular consumer brands, including:
- Kenvue’s Tylenol, Listerine, and Band-Aid
- Kimberly-Clark’s Cottonelle, Huggies, and Kleenex
“We will serve billions of consumers across every stage of life,” said Kimberly-Clark Chairman and CEO Mike Hsu.
The takeover is one of the largest corporate deals announced in 2025. Mike Hsu will lead as chairman and CEO of the merged company, with three Kenvue board members joining Kimberly-Clark’s board upon closing.
Author summary: Kimberly-Clark buys Kenvue for $48.7 billion.
More News
- Could Melatonin Be Silently Harming Your Heart?
- Live updates: Polls close in 2025 Yukon territorial elections
- Amaro: The Elixir of Health and Sociality You Can't Miss
- Yorgos Lanthimos Defends Bugonia's Strange Ending
- Macy’s Thanksgiving Day Parade: Which stars are joining this year’s lineup?
- Letter from Baltimore